Página 2 - Melhores Cordoma médicos - TOP-54 médicos

Lidera o Departamento de Lesões Ósseas Metastáticas do Ichilov Medical Center, com foco específico em cancros ósseos complexos, como o cordoma.

• Cirurgião ortopédico especializado em ortopedia oncológica
• Professor da Faculdade de Medicina da Universidade de Tel Aviv
• Formado pela Universidade Hebraica de Jerusalém
• Realizar estágios clínicos nos Estados Unidos
• Médico sénior num centro de ortopedia oncológica israelita

Professor Associado da Universidade Médica de Viena e Chefe Adjunto da sua Divisão Clínica de Oncologia – um dos principais centros de investigação do cancro na Áustria.

• Mais de duas décadas de especialização em oncologia médica e medicina interna
• Reconhecido internacionalmente pela sua experiência em terapias orientadas para tumores sólidos
• Foco na medicina oncológica personalizada e no tratamento baseado em biomarcadores
• Contribuição para a investigação translacional e conceção de novas estratégias de tratamento de precisão
• Consultor sénior para terapia sistémica individualizada contra o cancro na Wiener Privatklinik

O Professor Associado Dr. Yusuf Acikgoz traz experiência internacional da Ohio State University para o Hospital Universitário Lokman Hekim em Ancara.

• Especializar-se em Oncologia Médica com foco em ensaios clínicos
• Participar em estudos de Fase III, como CheckMate-649 e Fortitude-101
• Membro da American Society of Clinical Oncology (ASCO)
• Certificado em Boas Práticas Clínicas e Proteção de Seres Humanos

O Dr. Nail Paksoy traz expertise especializada em oncologia, com foco em casos complexos no Hospital Medipol Bahçelievler.

• Certificado em Oncologia Médica pela ESMO
• Publicar múltiplos estudos sobre cancros raros e tratamentos inovadores
• Participar ativamente em ensaios clínicos internacionais de oncologia
• Professor Associado na Universidade Medipol de Istambul

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

O Dr. Alemdar é especialista em oncologia médica no Complexo Hospitalar Medical Park Antalya, com ampla formação em medicina interna e oncologia.

• Certificado em oncologia médica desde 2018
• Mais de 15 anos de experiência médica em diversos hospitais
• Formação especializada na Faculdade de Medicina da Universidade Akdeniz
• Trabalhar com uma abordagem multidisciplinar para o tratamento abrangente do cancro

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Mais de 30 anos de experiência com especialização em viroterapia – uma das áreas mais recentes da imunologia – na Clínica Pallas.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduado pelo Instituto Médico de Riga com residência em Medicina Interna
• Especialista em tratamentos imunológicos que podem ser adaptados a condições específicas

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

O Dr. Topcu traz experiência internacional do MD Anderson e do Sunnybrook Odette Cancer Center para o Hospital Universitário Biruni.

• Especializar-se em cancros raros, incluindo cordoma e sarcomas
• Membro da ESMO e ASCO – padrões oncológicos globais
• Formação em instituições de topo nos EUA, Canadá e Turquia
• Trabalhar em múltiplos tipos de cancro com casos complexos

Especializado em radioncologia com formação pela Universidade de Marmara, reconhecida pelo seu rigoroso programa médico.

• Formado no Departamento de Radioncologia da Universidade de Marmara
• Conclusão da licenciatura em medicina na Universidade de Marmara
• A formação inclui experiência internacional no Azerbaijão

O Professor Associado Dr. Emrah Eraslan é especialista em oncologia, com vasta experiência no tratamento de vários tipos de cancro, incluindo casos raros como o cordoma, no Hospital Koru Ankara.

• Certificado em oncologia médica com mais de 12 anos de experiência
• Especializado em cancros da mama, próstata, pulmão e colorretal
• Contribuição para a investigação oncológica com inúmeras publicações
• Formado em instituições de prestígio, incluindo a Universidade de Ancara e o Hospital de Educação e Investigação Oncológica Dr. Abdurrahman Yurtaslan em Ancara